Clinical study of endoscopic endonasal conjunctivodacryocystorhinostomy with jones tube placement

Min Soo Park, Mi Jung Chi, Se Hyun Baek

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Purpose: To evaluate the efficacy of endoscopic endonasal primary conjunctivodacryocystorhinostomy (CDCR) and revision CDCR after primary CDCR. Methods: Twenty-four patients who had undergone endoscopic endonasal CDCR with a Jones tube and who were followed up for over 6 months at our hospital were reviewed retrospectively. Our analysis included success rate, operation times, and causes of failure. Results: The indications for revision CDCR were Jones tube prolapse and inadequate tube length. The initial success rate in the primary and revision groups were 78.6% (11/14) and 100% (10/10), respectively, and their mean operation times were 24 min (± 6.3) and 21 min (± 6.1), respectively. Main causes of failure included inaccurate tube length and abnormal tube position. Conclusions: Endoscopic endonasal CDCR appears to be a reasonable revision and primary approach, because it allows Jones tube length to be measured accurately during surgery, and an 18- to 20-mm Jones tube length was used in most cases.

Original languageEnglish
Pages (from-to)36-40
Number of pages5
JournalOphthalmologica
Volume221
Issue number1
DOIs
Publication statusPublished - 2006 Dec 1

Fingerprint

Prolapse
Clinical Studies

Keywords

  • Endoscopic endonasal conjunctivodacryocystorhinostomy
  • Jones tube
  • Revision conjunctivodacryocystorhinostomy

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Clinical study of endoscopic endonasal conjunctivodacryocystorhinostomy with jones tube placement. / Park, Min Soo; Chi, Mi Jung; Baek, Se Hyun.

In: Ophthalmologica, Vol. 221, No. 1, 01.12.2006, p. 36-40.

Research output: Contribution to journalArticle

@article{5060eea3b8e749638d1564df1823898a,
title = "Clinical study of endoscopic endonasal conjunctivodacryocystorhinostomy with jones tube placement",
abstract = "Purpose: To evaluate the efficacy of endoscopic endonasal primary conjunctivodacryocystorhinostomy (CDCR) and revision CDCR after primary CDCR. Methods: Twenty-four patients who had undergone endoscopic endonasal CDCR with a Jones tube and who were followed up for over 6 months at our hospital were reviewed retrospectively. Our analysis included success rate, operation times, and causes of failure. Results: The indications for revision CDCR were Jones tube prolapse and inadequate tube length. The initial success rate in the primary and revision groups were 78.6{\%} (11/14) and 100{\%} (10/10), respectively, and their mean operation times were 24 min (± 6.3) and 21 min (± 6.1), respectively. Main causes of failure included inaccurate tube length and abnormal tube position. Conclusions: Endoscopic endonasal CDCR appears to be a reasonable revision and primary approach, because it allows Jones tube length to be measured accurately during surgery, and an 18- to 20-mm Jones tube length was used in most cases.",
keywords = "Endoscopic endonasal conjunctivodacryocystorhinostomy, Jones tube, Revision conjunctivodacryocystorhinostomy",
author = "Park, {Min Soo} and Chi, {Mi Jung} and Baek, {Se Hyun}",
year = "2006",
month = "12",
day = "1",
doi = "10.1159/000096520",
language = "English",
volume = "221",
pages = "36--40",
journal = "Ophthalmologica",
issn = "0030-3755",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Clinical study of endoscopic endonasal conjunctivodacryocystorhinostomy with jones tube placement

AU - Park, Min Soo

AU - Chi, Mi Jung

AU - Baek, Se Hyun

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Purpose: To evaluate the efficacy of endoscopic endonasal primary conjunctivodacryocystorhinostomy (CDCR) and revision CDCR after primary CDCR. Methods: Twenty-four patients who had undergone endoscopic endonasal CDCR with a Jones tube and who were followed up for over 6 months at our hospital were reviewed retrospectively. Our analysis included success rate, operation times, and causes of failure. Results: The indications for revision CDCR were Jones tube prolapse and inadequate tube length. The initial success rate in the primary and revision groups were 78.6% (11/14) and 100% (10/10), respectively, and their mean operation times were 24 min (± 6.3) and 21 min (± 6.1), respectively. Main causes of failure included inaccurate tube length and abnormal tube position. Conclusions: Endoscopic endonasal CDCR appears to be a reasonable revision and primary approach, because it allows Jones tube length to be measured accurately during surgery, and an 18- to 20-mm Jones tube length was used in most cases.

AB - Purpose: To evaluate the efficacy of endoscopic endonasal primary conjunctivodacryocystorhinostomy (CDCR) and revision CDCR after primary CDCR. Methods: Twenty-four patients who had undergone endoscopic endonasal CDCR with a Jones tube and who were followed up for over 6 months at our hospital were reviewed retrospectively. Our analysis included success rate, operation times, and causes of failure. Results: The indications for revision CDCR were Jones tube prolapse and inadequate tube length. The initial success rate in the primary and revision groups were 78.6% (11/14) and 100% (10/10), respectively, and their mean operation times were 24 min (± 6.3) and 21 min (± 6.1), respectively. Main causes of failure included inaccurate tube length and abnormal tube position. Conclusions: Endoscopic endonasal CDCR appears to be a reasonable revision and primary approach, because it allows Jones tube length to be measured accurately during surgery, and an 18- to 20-mm Jones tube length was used in most cases.

KW - Endoscopic endonasal conjunctivodacryocystorhinostomy

KW - Jones tube

KW - Revision conjunctivodacryocystorhinostomy

UR - http://www.scopus.com/inward/record.url?scp=33845899105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845899105&partnerID=8YFLogxK

U2 - 10.1159/000096520

DO - 10.1159/000096520

M3 - Article

C2 - 17183199

AN - SCOPUS:33845899105

VL - 221

SP - 36

EP - 40

JO - Ophthalmologica

JF - Ophthalmologica

SN - 0030-3755

IS - 1

ER -